Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer

Rabah, Danny; Abusamra, Ashraf; Ahmad, Imran; Alghamdi, Abdullah; Alkhateeb, Sultan; Alkushi, Hussain; Al‐Μansour, Mubarak; Alolayan, Ashwaq; Alotaibi, Mohammed; Alsharm, Abdullah; Bazarbashi, Shouki; Mahmood, Rana; Murshid, Esam

doi:10.4103/0974-7796.140959

Cited by 3 publications

(3 citation statements)

References 113 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the cause of increased PCa incidence rates in Saudi Arabia and other countries remains unclear, it is hypothesized that increased obesity and unhealthy dietary intake may play a significant role 10 . Additionally, improved documentation and registry reporting may have contributed to the increase in cases witnessed in Saudi Arabia 11 .…”

Section: Discussionmentioning

confidence: 99%

Prostate cancer among Saudis: a registry review

Alasker,

Arabi,

Alghafees

et al. 2023

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Background: Policy makers in Saudi Arabia greatly rely on published studies to make major public health decisions. Prostate cancer (PCa) studies in Saudi Arabia are either outdated or limited to local regions. Aim: We aim to analyze the Saudi Cancer Registry to determine the incidence of PCa across all regions of the Kingdom and the risk factors of poor prognosis in the population. Methods: Patients diagnosed with primary PCa from 1 January 2008 to 31 December 2017 were included in the study from the Saudi Cancer Registry. Incidence rates and risk factors for poor survival were calculated. Results: A total of 3607 PCa patients were retrieved. Prostate cancer incidence rates ranged from 0.2 to 1.4 per 100,000. Most of the patients were aged 60 and older (86.5%; n=3120), married (97%; n=3497) and lived in the central region (38.1%; n=1375). Mean age at diagnosis was 71.1 (10.8) years. Over half of all tumors were poorly differentiated (64.2%; n=2317), and localized (60.4%; n=2180). The all-time metastasis rate reached 31.4% (n=1131). The lowest mean survival was in those with distant metastasis (P=0.039). Age groups, marital status, tumor morphology, place of residency, and grade were not proven to significantly influence survival. Conclusion: The high metastasis rate and evidence of greater incidence of newly diagnosed metastatic PCa indicate that the idea of select screening for certain high-risk populations is not farfetched. We encourage promotion of awareness regarding PCa risk factors and screening to optimize prognosis and minimize late presentations and high metastasis rates.

show abstract

Section: Discussionmentioning

confidence: 99%

Prostate cancer among Saudis: a registry review

Alasker,

Arabi,

Alghafees

et al. 2023

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

show abstract

“…This is an update to the previously published Saudi guidelines for the evaluation, medical, and surgical management of prostate cancer. [ 2 3 ] It is categorized according to the stage of the disease using the tumor node metastasis staging system 7 th edition. The guidelines are presented with supporting evidence level according to an article accompanying the guidelines 1 st edition, as well as, the scope, purpose, and methods of these guidelines.…”

Section: Purpose and Methodsmentioning

confidence: 99%

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer

et al. 2016

Self Cite

View full text Add to dashboard Cite

This is an update to the previously published Saudi guidelines for the evaluation, medical, and surgical management of patients diagnosed with prostate cancer. It is categorized according to the stage of the disease using the tumor node metastasis staging system 7th edition. The guidelines are presented with supporting evidence level, they are based on comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi oncology society and Saudi urological association. Considerations to the local availability of drugs, technology, and expertise have been regarded. These guidelines should serve as a roadmap for the urologists, oncologists, general physicians, support groups, and health care policy makers in the management of patients diagnosed with adenocarcinoma of the prostate to.

show abstract

“…The present guidelines are an update to the previously published Saudi Oncology Society guidelines for the evaluation, medical, and surgical management of prostate cancer. [ 2 3 4 ] More than 95% of primary prostate cancers are adenocarcinomas, so these guidelines are focused on this category of prostate tumors. This cancer is categorized according to the stage of the disease using the tumor node metastasis staging system 7 th edition.…”

Section: Introductionmentioning

confidence: 99%

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for prostate cancer 2017

et al. 2018

Self Cite

View full text Add to dashboard Cite

This is an update to the previously published Saudi guidelines for the evaluation and medical and surgical management of patients diagnosed with prostate cancer. Prostate cancer is categorized according to the stage of the disease using the tumor node metastasis staging system 7th edition. The guidelines are presented with supporting evidence levels based on a comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi Oncology Society and Saudi Urological Association. Local factors, such as availability, logistic feasibility, and familiarity of various treatment modalities, have been taken into consideration. These guidelines should serve as a roadmap for the urologists, oncologists, general physicians, support groups, and health-care policymakers in the management of patients diagnosed with adenocarcinoma of the prostate.

show abstract

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer

Cited by 3 publications

References 113 publications

Prostate cancer among Saudis: a registry review

Prostate cancer among Saudis: a registry review

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for prostate cancer 2017

Contact Info

Product

Resources

About